Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Biao Niu, Sidong Wei, Jianjun Sun, Huibo Zhao, Bing Wang & Guoyong Chen. (2022) Deciphering the molecular mechanism of tetrandrine in inhibiting hepatocellular carcinoma and increasing sorafenib sensitivity by combining network pharmacology and experimental evaluation. Pharmaceutical Biology 60:1, pages 75-86.
Read now
Read now
Articles from other publishers (12)
Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi & Zhijie Xu. (2024) Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial–Mesenchymal Transition in an Ovarian Tumor. Journal of Natural Products.
Crossref
Crossref
Chenge Zhao, Lulu Qiu, Di Wu, Ming Zhang, Wanying Xia, Huiyi Lv & Lichun Cheng. (2023) Targeted reversal of multidrug resistance in ovarian cancer cells using exosome‑encapsulated tetramethylpyrazine. Molecular Medicine Reports 29:2.
Crossref
Crossref
Liangliang Shi, Shuaizhe Wang, Shangzu Zhang, Jiawei Wang, Yaping Chen, Yangyang Li, Zhiwei Liu, Sichen Zhao, Benjun Wei & Liying Zhang. (2023) Research progress on pharmacological effects and mechanisms of cepharanthine and its derivatives. Naunyn-Schmiedeberg's Archives of Pharmacology 396:11, pages 2843-2860.
Crossref
Crossref
Pankaj Garg, Rachana Garg, David Horne, Sanjay Awasthi, Ravi Salgia & Sharad S. Singhal. (2023) Prognostic significance of natural products against multidrug tumor resistance. Cancer Letters 557, pages 216079.
Crossref
Crossref
Kaiyue Wang, Yi Wang, Junyuan Yan, Chunyu Hou, Xinqin Zhong, Yucui Zhao, Qian Zhou & Xiaoying Wang. (2022) Network Pharmacology and Molecular Docking Integrated Strategy to the Screening of Active Components and Mechanisms of Stephaniae Tetrandrae Radix on Breast Cancer. Processes 10:11, pages 2340.
Crossref
Crossref
Liuying Mo, Fan Zhang, Feng Chen, Lei Xia, Yi Huang, Yuemi Mo, Lingqiu Zhang, Daquan Huang, Shunli He, Jiagang Deng, Erwei Hao & Zhengcai Du. (2022) Progress on structural modification of Tetrandrine with wide range of pharmacological activities. Frontiers in Pharmacology 13.
Crossref
Crossref
Yan Zhang, Hai-Yun Zhang, Zhengping Jiang, Yuan-Lu Cui & Qiang-Song Wang. (2022) Targeted glutamine-decorated chitosan nanoparticles with enhanced synergism of chemotherapeutic and natural medicine for hepatic carcinoma therapy. Materials & Design 220, pages 110842.
Crossref
Crossref
Chuansheng Yang, Zhikai Mai, Can Liu, Shuanghong Yin, Yantao Cai & Chenglai Xia. (2022) Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways. Molecules 27:11, pages 3513.
Crossref
Crossref
Jia-Yue Xu, Fang-Yuan Liu, Shao-Xuan Liu, Liang-Zhen Xie, Jia Li, Yu-Ting Ma & Feng-Juan Han. (2021) Plant-Derived Chinese Medicine Monomers on Ovarian Cancer via the Wnt/β-Catenin Signaling Pathway: Review of Mechanisms and Prospects. Journal of Oncology 2021, pages 1-10.
Crossref
Crossref
Yanna Zhang, Xun Wang & Xiancheng Chen. (2021) Identification of core genes for early diagnosis and the EMT modulation of ovarian serous cancer by bioinformatics perspective. Aging 13:2, pages 3112-3145.
Crossref
Crossref
Xuehua Luo, Huijun Xie, Li Han, Qiaoming Zhong, Meng Xu & Ling Jin. (2021) Integrated Network Pharmacology and Molecular Docking to Reveal the Mechanism of Tetrandrine in Tumor Chemoresistance. Oncologie 23:3, pages 425-438.
Crossref
Crossref
Malvina Koni, Veronica Pinnarò & Maria Felice Brizzi. (2020) The Wnt Signalling Pathway: A Tailored Target in Cancer. International Journal of Molecular Sciences 21:20, pages 7697.
Crossref
Crossref